News

The pharmaceutical industry estimates President Donald Trump’s new drug pricing proposal could cost drug companies as much as ...
The deficit ballooned to $140.5 billion in March, as businesses stockpiled goods to get ahead of tariffs imposed the ...
Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.
Pharmaceutical imports to the U.S. surged in March as drugmakers stocked up ahead of potential U.S. tariffs on their products ...
President Donald Trump said on Wednesday that there will be a tariff "wall" for pharmaceutical companies operating in the ...
President Donald Trump on Monday signed an executive order to incentivize drug manufacturing in the U.S., streamlining the ...
Wall Street's major indexes faced declines as President Trump's announcement of upcoming pharmaceutical tariffs rekindled ...
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...
Merck broke ground on a $1B, 470K SF biotech facility last month at the Chestnut Run Innovation & Science Park in Wilmington, ...
Preclinical data supports the advancement of oral Ketamir-2 as a safe, next-generation alternative to ketamine, with ongoing momentum in Phase I clinical trial enrollment ...
Dr. Falk Pharma, a research-based pharmaceutical company specializing in digestive and metabolic medicine, today announced ...
A manufacturer of capsules and tablets for the pharmaceuticals industry is scouting Asia for new partners. A steel component ...